EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells
about
Recent advances on tea polyphenolsRegulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsDietary antioxidants protect gut epithelial cells from oxidant-induced apoptosisNovel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular CarcinomaBroad targeting of angiogenesis for cancer prevention and therapyInhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancerGreen tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude miceInhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro.Steep your genes in health: drink tea.Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells.Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitroAnalysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models.Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts.(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cellsInhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines.(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.Potential of the bioflavonoids in the prevention/treatment of ocular disordersImplications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway.Green tea polyphenols as proteasome inhibitors: implication in chemoprevention.Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemopreventionEpigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer.Campomanesia adamantium Peel Extract in Antidiarrheal Activity: The Ability of Inhibition of Heat-Stable Enterotoxin by Polyphenols.Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder CancerThe HMG-CoA reductase pathway, statins and angioprevention.Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.Overview of major classes of plant-derived anticancer drugsEGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression.Green tea catechins inhibit angiogenesis through suppression of STAT3 activation.Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals.Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate.Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye.Plants and their active compounds: natural molecules to target angiogenesis.Tea polyphenols, their biological effects and potential molecular targets.The protective effects of green tea extract against L-arginine toxicity to cultured human mesangial cellsExpanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents.Natural products and colon cancer: current status and future prospects.Molecular mechanisms of green tea polyphenolsCrystal engineering of green tea epigallocatechin-3-gallate (EGCg) cocrystals and pharmacokinetic modulation in rats.
P2860
Q24616890-8DDE248C-8015-4901-B367-EA9A6379161AQ24631327-C6BFCE6B-3530-4E16-B0FB-3CC0E8706A29Q24797247-C4582E20-5284-4B85-B718-34B30A7160D9Q26767372-03AB2186-8B28-4C09-B2BE-F2B1EED78989Q27002903-9C48B022-0FFE-4298-BB6E-E742FAD9B182Q33258696-ECF29DE9-2CA4-4ED8-9544-674AC383D8E5Q33712325-1E13CD10-61F5-43C6-A60E-F37EB90BA594Q33722456-763FA852-94A2-447E-81BC-C3736D1FBF42Q33763749-F6747611-991E-41FC-A6AA-E7E0B8F25E1DQ33806328-5BC788E5-1B03-4703-81C7-46DD1073AA2CQ33829207-04809D65-774C-444B-980C-49E6BF8FF304Q33893381-4BDEE7A1-A649-49E1-9EC5-1A7E22F1DA3AQ34038797-CA7E0045-0EF9-487E-8198-91FBB45D1101Q34099507-B4BFD709-1D1D-4E69-93F3-77851FAE36B1Q34234351-4618EA0F-D06B-4A6F-9B34-D36C2D7D8C9DQ34532583-8C3953E1-5A8D-48A2-9262-BC97D04D3F95Q34667547-5028838B-345C-434E-9AEC-51EEC6B7EAACQ34993694-6C363144-DE1C-4DF4-A5F3-8EEB1F38E050Q35213983-D8B9D97F-812F-4AA7-9FB6-E9EBE1A050EEQ35568151-30ACB426-24BA-4F87-8541-4FF05B4EFA94Q35832071-750C213F-7B71-4B65-AD66-8FF24DF707A7Q35859243-C7A8F552-5EA8-4528-807E-B7B82594FC31Q36080818-0D11A35A-C5BD-4C6C-B068-ADD311CB7695Q36169609-5F2031D8-3945-4C11-B469-03E6442267B3Q36265124-458035A5-6E76-4CAB-B35F-73BE4445EFDCQ36414196-CCEDBCFE-4B5A-41D9-9A02-DF0121A84BA1Q36525391-F5690845-3D75-410A-8325-0E61567CDFACQ36735506-9F3AC17B-3ABA-4295-8CAE-D00EBF0C165CQ36831607-CE0DAFEB-9416-42FC-AD96-925B9D3177FBQ36876370-9135731B-410B-470F-BD5D-DEDA3A18D7C6Q36920740-6220E90C-059A-40A0-B6A7-B91FE6843649Q36943726-EA28172E-2A45-472B-BD5C-EDEE9404E761Q36989668-1757CF45-B849-45B3-9A39-CF8DC63B8653Q37059810-3032803F-9F70-4802-BB29-70E03C8AAA6DQ37070437-94C54B2A-E28B-4BE9-8FEC-65D3023EA234Q37078135-C21D117C-C149-49C5-9D78-82F7F9B29267Q37124747-1E58E056-4D4A-4580-80CD-691896D01A78Q37136990-BF7B4EEC-033E-4452-A0AF-D21640B68104Q37161937-AF6B54A1-A641-4EEB-9F27-4E2503FF6B3BQ37226778-07C4B645-5645-4DCB-AA11-2193A2DC1D43
P2860
EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
EGCG, a major component of gre ...... in human colon carcinoma cells
@ast
EGCG, a major component of gre ...... in human colon carcinoma cells
@en
EGCG, a major component of gre ...... in human colon carcinoma cells
@nl
type
label
EGCG, a major component of gre ...... in human colon carcinoma cells
@ast
EGCG, a major component of gre ...... in human colon carcinoma cells
@en
EGCG, a major component of gre ...... in human colon carcinoma cells
@nl
prefLabel
EGCG, a major component of gre ...... in human colon carcinoma cells
@ast
EGCG, a major component of gre ...... in human colon carcinoma cells
@en
EGCG, a major component of gre ...... in human colon carcinoma cells
@nl
P2093
P2860
P3181
P356
P1476
EGCG, a major component of gre ...... in human colon carcinoma cells
@en
P2093
C D Bucana
G E Gallick
P2860
P2888
P304
P3181
P356
10.1054/BJOC.2000.1691
P407
P577
2001-03-23T00:00:00Z
P5875
P6179
1019321821